Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2012
03/01/2012WO2012024784A1 Cell-protective peptides and uses thereof
03/01/2012US20120053318 Method of radiolabeling
03/01/2012US20120052574 Novel reagents for transfection of eukaryotic cells
03/01/2012US20120052569 Tag peptide having a protease recognition sequence and use thereof
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052104 Polypeptides and Antibacterial or Antiseptic Use of Same
03/01/2012US20120052034 Hair treatment composition with naturally - derived peptide identical to human hair
03/01/2012CA2809415A1 Cell-protective peptides and uses thereof
02/2012
02/29/2012EP2423218A1 Tag peptide having protease recognition sequence and utilization of same
02/29/2012EP2421887A1 Method for the manufacture of degarelix
02/29/2012EP2421885A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same
02/29/2012EP2421884A1 Peptide hydrolysate proteasome activators and compositions containing same
02/29/2012EP2421546A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
02/29/2012EP1572725B1 Chi-conotoxin peptides having a n-terminal pyroglutamic acid
02/29/2012CN1908010B Furin enzyme inhibitor of resisting HIV-1 and preparation method thereof
02/29/2012CN102365093A Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
02/29/2012CN102363627A Oligopeptide A and antibacterial use thereof
02/29/2012CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof
02/29/2012CN101851276B Preparation method and activity detection for antibacterial peptides
02/29/2012CN101798336B Anti-tumour compound with tracking function
02/29/2012CN101768210B Tumor targeting polypeptide and preparation method thereof
02/29/2012CN101538317B Polypeptide hydrous salt of direct thrombin inhibitor and synthesis method thereof
02/28/2012US8124725 PDGF-Rβ binders
02/28/2012US8124724 Peptides and related molecules that modulate nerve growth factor activity
02/28/2012US8124580 Apolipoprotein A1 mimetics and uses thereof
02/23/2012WO2012023781A2 Peptide having anti-red tide activities, and use thereof
02/23/2012WO2012023614A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded
02/23/2012WO2012022040A1 Hiv-1 virus membrane fusion inhibitor and use thereof
02/23/2012WO2012021964A1 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events
02/23/2012WO2012006732A9 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
02/23/2012WO2012001179A3 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1
02/23/2012WO2011160827A3 Novel jnk inhibitor molecules
02/23/2012US20120046591 Treatment devices and methods with extending elements
02/23/2012US20120046586 Skin treatment devices and methods with pre-stressed configurations
02/23/2012US20120046444 Peptide networks
02/23/2012US20120046443 Novel biomimetic peptoid polymers
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046219 Melanocortin receptor-specific peptides
02/23/2012US20120045819 Binding molecules for human factor viii and factor viii-like proteins
02/23/2012US20120045780 Signal biomarkers
02/23/2012US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof
02/23/2012US20120045468 Immunogenic Compositions and Uses Thereof
02/23/2012US20120045466 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120045465 Cancer antigen helper peptide
02/23/2012US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts
02/23/2012US20120045411 Short beta-defensin-derived peptides
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045393 Lhrh-ii peptide analogs
02/23/2012CA2808165A1 Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events
02/22/2012EP2420255A2 Polypeptide inhibitors of urokinase type plasminogen activator
02/22/2012EP2419440A1 Peptide ligands for clusterin and uses thereof
02/22/2012EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
02/22/2012EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
02/22/2012EP2371840A9 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
02/22/2012EP1968623B1 Bacteriocin inducer peptides
02/22/2012EP1788074B1 Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof
02/22/2012EP1255555B1 NON-MAMMALIAN GnRH ANALOG AND USES THEREOF IN REGULATING FERTILITY AND PREGNANCY
02/22/2012CN1854151B 多巴胺转运蛋白拟肽抑制剂及其应用 Peptidomimetic inhibitor of dopamine transporter and its application
02/22/2012CN102361979A Peptide capable of binding to immunoglobulin
02/22/2012CN102358751A Human fibrinogen-like protein 2 prothrombinase immunogenicity peptide and use thereof
02/22/2012CN101153054B 用于血管生成治疗的小肽及其应用 Angiogenic therapy for small peptide and its application
02/16/2012WO2012021796A2 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
02/16/2012WO2012020222A1 Compounds
02/16/2012WO2012020221A1 Compounds
02/16/2012WO2012020220A1 Compounds
02/16/2012WO2011115688A3 Integrin interaction inhibitors for the treatment of cancer
02/16/2012WO2005110456A8 T-cell death-inducing epitopes
02/16/2012US20120042399 Immunogenic peptides
02/16/2012US20120041172 Method for the manufacture of degarelix
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040915 Peptides and nanoparticles for therapeutic and diagnostic applications
02/16/2012US20120040912 Proteasome-activating anti-aging peptides and compositions containing same
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040892 Methods and Compositions for the Treatment of Heart Failure and Other Disorders
02/16/2012US20120040889 Peptidomimetic macrocycles
02/16/2012US20120040376 Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040365 New competence stimulating peptide
02/16/2012US20120040338 RBM3 in Testicular Cancer Diagnostics and Prognostics
02/16/2012US20120039989 Erythrocyte-binding therapeutics
02/16/2012US20120039988 Cancer-targeting peptides and uses thereof in cancer therapy
02/16/2012US20120039925 Tuberculosis tb vaccine to prevent reactivation
02/16/2012US20120039922 Method and peptide for regulating cellular activity
02/16/2012US20120039894 Identification of therapeutic agents for hiv infection
02/16/2012US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof
02/16/2012CA2807685A1 Peptidomimetic macrocycles
02/15/2012EP2418213A1 Neuromedin u derivative
02/15/2012EP2417152A1 Process for isolating therapeutic peptide
02/15/2012EP1765861B1 Fgfr binding peptides
02/15/2012CN102356155A Neil3 peptides and vaccines including the same
02/15/2012CN102352398A Casein active single peptide as well as preparation method and application thereof
02/15/2012CN102351949A Xenorhabdus antibacterial peptide and application thereof in inhibiting growth of pathogenic fungi and bacteria
02/15/2012CN102351948A Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3
02/15/2012CN102351947A Ev71 early diagnosis method and reagent kit
02/15/2012CN102351946A Healing promoting polypeptide
02/15/2012CN102351941A Method for labeling functional molecules with <18>F
02/15/2012CN102349868A Preparation method of targeting folic acid-hydrophobic anticancer drug hydrogel
02/15/2012CN101696236B 一种固相合成阿托西班方法 Solid phase synthesis method atosiban
02/14/2012US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
02/14/2012US8114634 Methods, systems and reagents for improved immunodetection
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 423